H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6292214
[patent_doc_number] => 20100159440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'METHODS FOR IDENTIFYING AGENTS THAT MODULATE p44'
[patent_app_type] => utility
[patent_app_number] => 12/331285
[patent_app_country] => US
[patent_app_date] => 2008-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 36553
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20100159440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331285
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331285 | METHODS FOR IDENTIFYING AGENTS THAT MODULATE p44 | Dec 8, 2008 | Abandoned |
Array
(
[id] => 5574949
[patent_doc_number] => 20090142310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'METHOD OF TREATING INFLAMMATORY ARTHROPATHIES WITH SUPPRESSORS OF CPG OLIGONUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/325106
[patent_app_country] => US
[patent_app_date] => 2008-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 17130
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142310.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325106
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325106 | Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides | Nov 27, 2008 | Issued |
Array
(
[id] => 6538425
[patent_doc_number] => 20100221745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'ABNORMAL PRION PROTEIN BINDER, AND METHOD FOR DETECTION OF ABNORMAL PRION PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/742169
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7993
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221745.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742169 | Abnormal prion protein binder, and method for detection of abnormal prion protein | Nov 19, 2008 | Issued |
Array
(
[id] => 5452603
[patent_doc_number] => 20090068640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'METHODS FOR DETECTING AND INACTIVATING A PRION'
[patent_app_type] => utility
[patent_app_number] => 12/269479
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7594
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12269479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/269479 | METHODS FOR DETECTING AND INACTIVATING A PRION | Nov 11, 2008 | Abandoned |
Array
(
[id] => 5514868
[patent_doc_number] => 20090215175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'MODULATION OF THE POLIOVIRUS RECEPTOR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/269137
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 22253
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12269137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/269137 | MODULATION OF THE POLIOVIRUS RECEPTOR FUNCTION | Nov 11, 2008 | Abandoned |
Array
(
[id] => 9238678
[patent_doc_number] => 08603468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Neutralization of HCV'
[patent_app_type] => utility
[patent_app_number] => 12/741612
[patent_app_country] => US
[patent_app_date] => 2008-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 27901
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741612 | Neutralization of HCV | Nov 3, 2008 | Issued |
Array
(
[id] => 9704109
[patent_doc_number] => 08829174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'HCV vaccines and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 13/127008
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11608
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127008
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127008 | HCV vaccines and methods for using the same | Oct 28, 2008 | Issued |
Array
(
[id] => 6054614
[patent_doc_number] => 20110110974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN'
[patent_app_type] => utility
[patent_app_number] => 12/734397
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16855
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110974.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734397 | METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN | Oct 27, 2008 | Abandoned |
Array
(
[id] => 5473005
[patent_doc_number] => 20090246171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'AUTOMATIC SYSTEM FOR DOSE CONTROL IN TREATING HEPATITIS C USING INFUSION PUMPS'
[patent_app_type] => utility
[patent_app_number] => 12/257307
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8995
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12257307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/257307 | AUTOMATIC SYSTEM FOR DOSE CONTROL IN TREATING HEPATITIS C USING INFUSION PUMPS | Oct 22, 2008 | Abandoned |
Array
(
[id] => 8807990
[patent_doc_number] => 08445642
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-05-21
[patent_title] => 'Methods to differentiate protein conformers'
[patent_app_type] => utility
[patent_app_number] => 12/251456
[patent_app_country] => US
[patent_app_date] => 2008-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21812
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12251456
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/251456 | Methods to differentiate protein conformers | Oct 13, 2008 | Issued |
Array
(
[id] => 9977332
[patent_doc_number] => 09023643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Medicaments and methods for treating mesothelioma'
[patent_app_type] => utility
[patent_app_number] => 12/682457
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 5203
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12682457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682457 | Medicaments and methods for treating mesothelioma | Oct 9, 2008 | Issued |
Array
(
[id] => 5545417
[patent_doc_number] => 20090155294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'HCV VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/248587
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14499
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12248587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/248587 | HCV VACCINES | Oct 8, 2008 | Abandoned |
Array
(
[id] => 5278003
[patent_doc_number] => 20090130135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'HCV VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/248744
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14566
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12248744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/248744 | HCV VACCINES | Oct 8, 2008 | Abandoned |
Array
(
[id] => 5585015
[patent_doc_number] => 20090104217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Pharmaceutical Composition Comprising An Antigen'
[patent_app_type] => utility
[patent_app_number] => 12/248397
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4278
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12248397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/248397 | Pharmaceutical Composition Comprising An Antigen | Oct 8, 2008 | Abandoned |
Array
(
[id] => 5574937
[patent_doc_number] => 20090142298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/203813
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6104
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142298.pdf
[firstpage_image] =>[orig_patent_app_number] => 12203813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/203813 | Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C | Sep 2, 2008 | Abandoned |
Array
(
[id] => 10574172
[patent_doc_number] => 09296799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Process for isolation and purification of a target protein free of prion protein (PrPSC)'
[patent_app_type] => utility
[patent_app_number] => 12/733306
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7076
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733306
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733306 | Process for isolation and purification of a target protein free of prion protein (PrPSC) | Aug 24, 2008 | Issued |
Array
(
[id] => 5271029
[patent_doc_number] => 20090074805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Yeast-based Therapeutic for Chronic Hepatitis C Infection'
[patent_app_type] => utility
[patent_app_number] => 12/196439
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31934
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196439 | Yeast-based therapeutic for chronic hepatitis C infection | Aug 21, 2008 | Issued |
Array
(
[id] => 6070125
[patent_doc_number] => 20110044975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'TREATMENT OF PRION PROTEIN RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/672737
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17132
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044975.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672737
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672737 | TREATMENT OF PRION PROTEIN RELATED DISEASES | Aug 7, 2008 | Abandoned |
Array
(
[id] => 5984591
[patent_doc_number] => 20110097332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Composition and Method of Use for HCV Immunization'
[patent_app_type] => utility
[patent_app_number] => 12/672656
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 21489
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672656 | Composition and Method of Use for HCV Immunization | Aug 5, 2008 | Abandoned |
Array
(
[id] => 7488756
[patent_doc_number] => 08029785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases'
[patent_app_type] => utility
[patent_app_number] => 12/176793
[patent_app_country] => US
[patent_app_date] => 2008-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9586
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/029/08029785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12176793
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/176793 | Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases | Jul 20, 2008 | Issued |